What is Cerenome, Inc. (CNSY) stock price today?

Cerenome, Inc. (CNSY) is currently trading at $1.93, up 7.82% today.

What is CNSY P/E ratio?

Cerenome, Inc.'s P/E ratio is -0.32. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is CNSY return on equity (ROE)?

Cerenome, Inc.'s return on equity (ROE) is -394.17%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Cerenome, Inc.'s market cap?

Cerenome, Inc. has a market capitalization of $13.28M.

NASDAQ · Medical - Pharmaceuticals

Cerenome, Inc. (CNSY) Stock

$1.93 +7.82% NASDAQ: CNSY Healthcare

Valuation

Metric	Value
Price	$1.93
Market Cap	$13.28M
P/E Ratio	-0.32
P/B Ratio	2.88
P/S Ratio	3.81
EPS (TTM)	$21.72
52-Week High	$23.50
52-Week Low	$1.51
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-394.17%
ROA	-185.94%
ROCE	-483.25%
Gross Margin	-320.00%
Operating Margin	-300.00%
Net Margin	-620.70%
Debt/Equity	0.01
Current Ratio	1.25

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$5.0M	$6.0M	$5.0M
Operating Profit	$-12.0M	$-20.0M	$-13.0M	$-15.0M	$-15.0M
Net Profit	$-13.0M	$-20.0M	$-13.0M	$-13.0M	$-22.0M
EPS	$-444500.00	$-288750.00	$-106000.00	$-58.50	$-7.19
Op Margin	—	-8800.0%	-271.1%	-252.3%	-293.5%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$22.0M	$24.0M	$11.0M	$7.0M	$16.0M
Total Liabilities	$11.0M	$17.0M	$13.0M	$16.0M	$12.0M
Cash	$18.0M	$18.0M	$9.0M	$0	$9.0M
Borrowings	$7.0M	$6.0M	$4.0M	$3.0M	$1.0M

Latest News

Cerenome Selects XiFin Empower RCM for Revenue Cycle Management and Clearinghouse Services for CNSide Platform GlobeNewswire · Aug 6, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-10.0M	$-13.0M	$-13.0M	$-11.0M	$-21.0M
Investing Cash Flow	$0	$-2.0M	$0	$-4.0M	$-1.0M
Financing Cash Flow	$2.0M	$-1.0M	$0	$0	$19.0M
Net Cash Flow	$10.0M	$0	$-10.0M	$-8.0M	$9.0M
Free Cash Flow	$-10.0M	$-14.0M	$-13.0M	$-11.0M	$-21.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.61
FCF Yield	-147.15%
Quick Ratio	1.37
Interest Coverage	-8.56
Return 1Y	-73.48%
Return 3Y	-94.11%
Return 5Y	-99.51%

Ownership

Insiders Held1.84%

Institutions Held13.87%

Institutions Float Held14.12%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$336.64	-1.11%	38.93	$4.94T	0.32%
MSFTMicrosoft Corporation	$535.07	+2.38%	28.68	$3.97T	0.76%
GOOGLAlphabet Inc.	$351.66	+0.97%	16.94	$4.26T	0.26%
AMZNAmazon.com, Inc.	$262.43	+3.29%	19.82	$2.82T	0.00%
METAMeta Platforms, Inc.	$718.67	-0.31%	27.93	$1.83T	0.28%

About Cerenome, Inc.

Cerenome, Inc. is headquartered in US.

Cerenome, Inc. (CNSY) stock trades at $1.93 with a market capitalization of $13.28M. The stock is valued at a price-to-earnings (P/E) ratio of -0.32, price-to-book of 2.88, price-to-sales of 3.81. Over the past 52 weeks the stock has ranged between $1.51 and $23.50, and currently trades 91.8% below its 52-week high.

On profitability, Cerenome, Inc. generates a return on equity (ROE) of -394.17%, return on capital employed of -483.25%, an operating margin of -300.00%, a net profit margin of -620.70%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides